Literature DB >> 22662865

Regulation exerted by miRNAs in the promoter and UTR sequences: MDR1/P-gp expression as a particular case.

Julia D Toscano-Garibay1, Guillermo Aquino-Jarquin.   

Abstract

One of the common forms of multidrug resistance (MDR) is caused by activation of the mdr1 (ABCB1) gene, resulting in overexpression of P-glycoprotein (P-gp) and conferring cancer cell resistance to a broad range of chemotherapeutics. Recently, P-gp-mediated MDR has been associated with aberrant expression of microRNAs (miRNAs) in several types of cancer. miRNAs are small noncoding RNAs that regulate gene expression in a posttranscriptional manner through partial or total hybridization with specific sequences in the 3'-UTR of target mRNAs. Interestingly, there are at least two reports that suggest an additional regulation by miRNAs at the mdr1 promoter level. Here, we critically analyzed some of the miRNAs that regulate P-gp expression at two different levels: posttranscriptional and transcriptional. We proposed that the latter may occur through two possible scenarios: (1) direct miRNA hybridization with an active promoter and (2) triplex structure formation (double-stranded DNA/RNA) stabilized by Argonaute 2. Also, we classified transcriptional gene silencing (1) by homology, represented by small interfering RNAs directed to viral promoters, and (2) by complementarity (Watson-Crick/Hoogsteen base pairing), mediated by miRNAs. Transcriptional regulation could represent a new avenue of knowledge applicable to the modulation of other genes mediated by these noncoding RNAs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22662865     DOI: 10.1089/dna.2012.1703

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

1.  Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells.

Authors:  Alice C Rodrigues; Elida Adalgisa Neri; Sidney Veríssimo-Filho; Nancy Amaral Rebouças; Rosario D C Hirata; Ai-Ming Yu
Journal:  Eur J Pharm Sci       Date:  2016-08-26       Impact factor: 4.384

2.  Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.

Authors:  Sichuan Xi; Hong Xu; Jigui Shan; Yongguang Tao; Julie A Hong; Suzanne Inchauste; Mary Zhang; Tricia F Kunst; Leandro Mercedes; David S Schrump
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

3.  Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance.

Authors:  Katia Danza; Nicola Silvestris; Giovanni Simone; Michele Signorile; Luca Saragoni; Oronzo Brunetti; Manlio Monti; Annalisa Mazzotta; Simona De Summa; Anita Mangia; Stefania Tommasi
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

4.  Peptidylarginine deiminase IV promotes the development of chemoresistance through inducing autophagy in hepatocellular carcinoma.

Authors:  Tingting Fan; Changsong Zhang; Ming Zong; Qiudong Zhao; Xue Yang; Chong Hao; Hui Zhang; Shanshan Yu; Jinhu Guo; Ruhan Gong; Shasha Fan; Lixin Wei; Lieying Fan
Journal:  Cell Biosci       Date:  2014-08-26       Impact factor: 7.133

Review 5.  Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.

Authors:  Raquel C Maia; Flavia C Vasconcelos; Paloma S Souza; Vivian M Rumjanek
Journal:  Molecules       Date:  2018-01-07       Impact factor: 4.411

Review 6.  Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases.

Authors:  Atiyabanu N Saiyed; Abhay R Vasavada; S R Kaid Johar
Journal:  Futur J Pharm Sci       Date:  2022-04-01

Review 7.  miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer.

Authors:  Wei Meng; Yanli Li; Binshu Chai; Xiaomin Liu; Zhongliang Ma
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

8.  Expression of P-glycoprotein in human retinoblastoma and its clinical significance.

Authors:  Sumita Sethi; Manzoor Ahmad Malik; Sandeep Goswami; Parul Saxena; Arpna Srivastava; Seema Kashyap; Neelam Pushker; Mandeep Singh Bajaj; Sameer Bakhshi; Jasbir Kaur
Journal:  Tumour Biol       Date:  2014-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.